Adapt Pharma recently acknowledged the U.S. Drug Enforcement Administration's new guidance rules for first responders related to the hazards of fentanyl exposure.
Police officers and first responders in multiple states have overdosed because of accidental exposure when responding to scenes involving fentanyl, carfentanil and other highly potent powdery substances. The DEA recently released a briefing guide for first responders about the threat of inhalation or touching powdery substances associated with the drugs.
“These new synthetic opioids are more potent than commonly used opioids like morphine, oxycodone or heroin and may remain in an individual’s system for longer periods of time,” Dr. Daniel Ventricelli, assistant professor at the Philadelphia College of Pharmacy, said in a statement. “Opioid overdoses associated with illicit fentanyl substances have been shown to respond to naloxone when administered quickly and at a large enough dose as supported by data from the Swedish STRIDA project.”
Adapt Pharma noted it will continue to offer Narcan nasal spray, the only FDA-approved nasal naloxone for treating overdoses, to law enforcement at a discounted rate.
Alerts Sign-up